This tentative approval is the bioequivalent to Lamictal, a registered trademark of glaxosmithkline. Lamictal tablets had US sales of approximately $1.89 ...
L) Lamictal Tablets, which had US sales of approximately $1.97 million for the 12 months ending Sept. 30, 2007. 12/12/2007 7:20:15 AM RCG Starboard Advisors ...
... approval from the US Food and Drug Administration to market Lamotrigine tablets, the generic version of glaxosmithkline's antiepileptic drug Lamictal. ...
Mylan Inc. said it has received tentative approval from the Food and Drug Administration to market the generic version of glaxosmithkline's Lamictal, ...
Lamotrigine Tablets are the generic version of glaxosmithkline's Lamictal(R) Tablets, which had US sales of approximately $1.97 million for the 12 months ...
L) Lamictal Tablets, which had US sales of approximately $1.97 million for the 12 months ending Sept. 30, 2007. 12/12/2007 7:20:15 AM RCG Starboard Advisors ...
... development of a variety of significant new products, including AZT, the anti-HIV/AIDS therapy, Lamictal for Epilepsy and the anti-Herpes drug Zovirax. ...
... development of a variety of significant new products, including AZT, the anti-HIV/AIDS therapy, Lamictal for Epilepsy and the anti-Herpes drug Zovirax. ...
... uncontrolled despite being on newer, more effective treatments such as levetiracetam (Keppra), lamotrigine (Lamictal) and oxcarbazepine (Trileptal). ...
... 2009. this tentative approval is the bioequivalent to lamictal(r), a registered trademark of glaxosmithkline (gsk). lamictal(r) tablets had us sales of ...